Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 4/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | SLC6A9 | P48067 | 4/20 | 0.45 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.41 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.40 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.40 |
| ▸ | PTPRC | P08575 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19953373 | 0.86 | SLC6A9 (0.49) | PPARGPPARAMAPTSLC6A9LTB4R | |
| SCHEMBL4849668 | 0.80 | SLC6A9 (0.42) | MAPTSLC6A9HDAC6 | |
| SCHEMBL11983237 | 0.80 | SLC6A9 (0.42) | MAPTSLC6A9HDAC6 | |
| SCHEMBL2783444 | 0.79 | SLC6A9 (0.43) | MAPTSLC6A9HDAC6 | |
| SCHEMBL11983239 | 0.78 | SLC6A9 (0.43) | MAPTSLC6A9 | |
| SCHEMBL19953474 | 0.73 | SLC6A9 (0.41) | SLC6A9 | |
| SCHEMBL13311022 | 0.72 | DPP4 (0.45) | MAPTSLC6A9HDAC6 | |
| SCHEMBL11983236 | 0.72 | DPP4 (0.45) | MAPTSLC6A9HDAC6 | |
| SCHEMBL1107031 | 0.72 | MAPT (0.47) | MAPT | |
| SCHEMBL2779853 | 0.72 | SLC6A9 (0.42) | PPARGPPARAMAPTSLC6A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190194386-A1 | Conducting Polymers and Uses Thereof | AUCKLAND UNISERVICES LIMITED (NZ) | 2019-06-27 | — | — | US | disclosed |
| US-20190194386-A1 | Conducting Polymers and Uses Thereof | AUCKLAND UNISERVICES LIMITED (NZ) | 2019-06-27 | — | — | US | disclosed |
| WO-2018047101-A1 | CONDUCTING POLYMERS AND USES THEREOF | AUCKLAND UNISERVICES LIMITED (NZ) | 2018-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194386-A1 | Conducting Polymers and Uses Thereof | POLI, PARG, PARN | PPARG 4697/4885PPARA 4050/4885MAPT 2099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.